Self Injection Device Market (Updated Version Available)

The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.

An auto-injector is a medical device designed to deliver a dose of a particular drug.

The global average price of Self-Injection Device is in the increasing trend, from 14.4 USD/Unit in 2012 to 15.2 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Self-Injection Device is widely used for insulin injection, epinephrine injection and other field. The most proportion of Self Injection Device is used for insulin injection, and the proportion in 2016 is 86.5%. The trend of self-injection devices used for insulin injection is decreasing.
Europe is the largest consumption place, with a consumption market share nearly 42% in 2016. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.

The report offers detailed coverage of Self Injection Device industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Self Injection Device by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report forecast global Self Injection Device market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Self Injection Device market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier

At the same time, we classify Self Injection Device according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Reusable Self Injection Device
Disposable Self Injection Device
Market by Application
Insulin Injection
Epinephrine Injection
Other

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Self Injection Device market for the forecast period 2021 - 2025?
• What are the driving forces in the Self Injection Device market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Self Injection Device industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?